Why the study?
Does genetic background (MTHFR and PON1 polymorphisms) influence the changes in cardiovascular risk markers following intense physical activity in male water polo players?
Observational (n=28)
Does genetic background (MTHFR and PON1 polymorphisms) influence the changes in cardiovascular risk markers following intense physical activity in male water polo players?
MTHFR and PON1 gene polymorphisms may increase susceptibility to elevated cardiovascular risk markers (homocysteine and oxidative stress) following intense physical activity in elite athletes.
Answers are grounded in this paper and cite their sources.
Genotype may heighten post-exercise homocysteine in elite athletes; leaves open whether screening alters cardiovascular outcomes.
Methylene-tetrahydrofolate reductase (MTHFR) and paraoxonase 1 (PON1) gene polymorphisms have been associated with hyperhomocysteinemia and oxidative stress increase, that are established cardiovascular risk factors. Given that intense physical activity may increase the susceptibility to adverse cardiovascular outcomes, here we investigated the effects of MTHFR C677T and A1298C as well as PON1 Q192R gene polymorphisms on cardiovascular risk markers in twenty-eight male water polo elite players. The mean plasma levels of homocysteine (Hcy) and advanced oxidation protein products (AOPP) were above reference limits in resting conditions, and increased after competition. Moreover, a positive correlation was found between Hcy and AOPP concentrations, and also between their variations (ratio post-exercise/pre-exercise values) and the variations of lactic dehydrogenase (LDH) and creatine kinase (CK) activities, known as muscle damage markers. The highest Hcy and AOPP values were found in subjects having either MTHFR CT/AC or TT/AA, and PON1 QR192 genotype, respectively. After exercise, Hcy concentrations significantly increased in CT/AC or TT/AA subjects than in athletes having other MTHFR genotypes. A training-induced increase in plasma levels of LDH and CK activities, as well as myoglobin concentrations, was also observed, even if significant differences were found only for CK activity in athletes with MTHFR CT/AC or TT/AA athletes.
No takes yet. Share an insight, caveat, or question.
Mauro et al. (2018) conducted an observational in Cardiovascular risk markers (n=28). MTHFR C677T/A1298C and PON1 Q192R gene polymorphisms vs. Other genotypes was evaluated on Plasma levels of homocysteine (Hcy) and advanced oxidation protein products (AOPP).
Synapse has enriched 10 related papers. Consider them for comparative context: